Investment firm offers to buy Vancouver, B.C.-based biotech Zymeworks for $733M in cash by Charlotte Schubert on April 28, 2022April 28, 2022 at 6:30 pm Global investment firm All Blue Capital has offered to buy Zymeworks, a public biotech company based in Vancouver, B.C., with operations in Seattle. All Blue delivered a letter to the… Read More